Latest Auxilium Pharmaceuticals Inc. Stories

2014-11-10 08:33:18

- Auxilium to exercise the exclusive option to expand the field of its license of CCH to include the potential treatment of canine lipoma LYNBROOK, N.Y., Nov.

2014-11-03 08:29:49

Multiple Presentations Designed to Enable a Better Understanding of the Safety and Efficacy Profile of XIAFLEX for Treatment of Peyronie's Disease CHESTERBROOK, Pa., Nov.

2014-10-30 08:33:59

$109.6 Million in 3Q 2014 Net Revenues Driven by Strong XIAFLEX Growth; Company Returns to Profitability with 3Q Non-GAAP EPS of $0.27 per Share CHESTERBROOK, Pa., Oct.

2014-10-21 08:33:47

- Label expansion to broaden patient base who may benefit from nonsurgical collagenase therapy LYNBROOK, N.Y., Oct.

2014-10-20 20:26:38

Estimated 35-40 Percent of Surgical Procedures to Treat DC Have Been Performed on Multiple Joints CHESTERBROOK, Pa., Oct.

2014-10-09 08:26:55

- Auxilium Shareholders to Receive $33.25 Per Share DUBLIN and CHESTERBROOK, Pa., Oct.

2014-09-22 08:27:53

Board Unanimously Reaffirms Recommendation of QLT Transaction CHESTERBROOK, Pa., Sept. 22, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc.

2014-09-18 08:28:56

Data Support CCH could be Used to Treat Two Affected Joints Concurrently; Positive Results Presented from Additional Studies Evaluating CCH Retreatment for Recurrent Contracture CHESTERBROOK,

Word of the Day
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.